--

-'-----~

OMKAR PHARMACHEM LIMITED

CIN L24231GJ1995PLC025276
501, Mahakant Building,
Opp. V.S. Hospital,
Ashram road, Ellisbridge,
Ahmedabad-380 006.
Website www.omkarpharmachem.co.in
Email investors.opl@gmail.com

Date: 30/05/2016
To,
Bombay Stock Exchange Limited,
Phiroz Jeejeebhoy Towers,
Dalal Street,
Mumbai-400001
Sub: - Audited Financial Result for the year and quarter ended on 31st March.
2016 under Regulation 33 of the of the SEBI (Listing Obligation And Disclosure
Requirement) RegMlation 2015
Company Scrip Code: 532167
Dear Sir,
Pursuant to the provisions of Regulation 33 of the of the SEBI (Listing Obligation And
Disclosure Requirement) Regulation 2015, please find enclosed herewith, copy of the
1)
2)
3)
4)

Audited Financial Results for the year and quarter ended 31St March, 2016.
Statement of Asset and Liability of the company.
Audit Report issued by the statutory auditor of the company.
Form A (for Audit Report with unmodified opinion)-standalone.

The aforesaid result has been approved by the Board of Directors at their meeting held on
30th May, 2016.
This is for your information and record.
Thanking You,
Yours faithfully,
For Omkar Pharmachem

Limited

~~

(Anurag Sharma)
Managing Director
DIN 02289261
Add: A-727, Sarita Vihar, New Delhi, 110076
Encl: a/a

OMKAR PHARMACHEM LIMITED

CIN L24231GJ1995PLC025276
501, Mahakant Building,
Opp. V.S. Hospital,
Ashram road, Eltisbridge,
Ahmedabad-380 006.
Website www.omkarpharmachem.co.in
Email investor~.opl@gmail.com

OMKAR PHARMACHEM

LIMITED

Regd. Off. SOl, Mahakant Bulding, opp: V.S. Hospital, Ashram Road, Ellisbridge, Ahmedabad-380006
CIN: L24231GJ1995PLC025276
Statement

of Standalone

Sr.

Particulars

No.

(Refer notes Below)

Website: www.omkarpharmachem.co.in
Audited Results for the Quarter

Quarter
31-03-2016
(audited)

! Income from operations

a)Net Sales! Income from Operations
b)Other Operating Income
2

Expenses
a) Employee benefits expense
b) Other Expenses
Total Expenses

3
4

5
6
7

8
9

Profit(Loss) from operations before Other income,

Finance cost and exceptional items(I-2)
Other Income
Profit(Loss) before Finance cost and exceptional
items(3+4)
Finance Costs
Profit(Loss) from Ordinary Activities before Taxes but
before exceptional items ( 5-6)
exceptional items
Profit(Loss) before Taxes( 5-6)

10 Tax Expence
11 Net Profit(Loss)

for the period (7-8)

12 Paid up Equity Share Capital (Face Value Rs. IO/-each)

(Rs in lacs except per share data)

Year ended 00

Ended on

31-12-2015
(unaudited)
0.00

Total income from Operations

Email: investors.opl@gmail.com

and Year Ended on 31st March 2016

31-03-2015
(audited)

31-03-2016
(audited)

31-03-2015
(audited)

0.00
0.00

0.00
0.00

0.00
0.00

0.00

0.00
0.00

0.00

0.00

0.00

0.00

0.94
2.07

0.62
0.76
1.38

2.79
9.06
11.85

2.46

3.01

0.62
0.87
1.49

-3.01
0.03

-1.49
0.00

-1.38
0.00

-11.85

-6.13

0.14

0.00

-2.98
0.00

-1.49

-1.38

-11.71

0.00

0.00

0.00

-6.13
0.00

-2.98
0.00

-1.49

-1.38

-11.71

0.00

0.00

0.00

-2.98
0.00

-1.49

-1.38

-11.71

0.00

0.00

0.00

0.00

3.67
6.13

-6.13
0.00
-6.13
0.00

-2.98

-1.49

-1.38

-11.71

-6.13

1008.37

1008.37

1008.37

1008.37

1008.37

-81.00

-81.00

-74.87

-81.00

-74.87

-0.0296

-0.0148

-0.0137

-0.1161

-0.0608

13 Reserves excluding Revaluation Reserves as per

Balancesheet of previous year
14 Earniog Per Share(before & after extraordinary
items)(ofRs. 10 each)(not annualised)
Basic and diluted Rs.
Notes:

1. The accounting

standard

regarding

segment reporting

is not applicable

to the company

as there is no segment.

2. The above results have been reviewed by the audit committee & approved by the Board of Directors at there respective meetings held
on 30th May 2016.
3. the figures oflast quarter are the balancing figures between audited figures in respect of the full financial year and the published year-to-date
figures upto the third quarter of the current financial year.
4. Corrosponding previous period figures are regrouped/rearranged

whereever necessary, to make them comparable.

For Omkar

Place:

Pharmachem

Limted

Alunedabad

Date: 30th May, 2016

A-727,

Sarita Vihar,

New delhi -110076

OMKAR PHARMACHEM LIMITED

CIN L24231GJ1995PLC025276
501, Mahakant Building,
Opp, V.S. Hospital,
Ashram road, Ellisbridge,
Ahmedabad-380 006.
Website www.omkarpharmachem.co.in
Email investors.opl@gmail.com
I
I

Statement of Assets and Liabilities

Sr. Particulars
No

31-03-2016 31-03-2015
(Audited) Rs. In lacs

A EQUITY AND LIABILITIES

1 Shareholders' funds
I

-92.71

1008.37
-81.00

915.66

927.37

a) Long term borrowings

0.00

0.00

b) Long term provisions

0.00

0.00

0.00

0.00

0.00
4.44

1.71

Sub-total Shareholders'
2

I
1

Non-current

Sub-total Non-current
3

I
,,i
,
,,

Current Liabilities
b) Trade Payables
c) Other current Liabilities
Sub-total- Current Liabilities
TOTAL- EQUITY AND LIABILITIES

b) Non- current investments

c) Deferred tax assets (net)

56.36

13.01

972.02

940.38

1.11

1.11

930.00

930.00

Sub-total2

Non Current Assets

0.00

0.00

0.00
0.18

0.00
0.19

931.29

931.30

0.00
7.46

0.00
7.46

33.20
0.00
0.Q7

0.33
0.00
1.29

d) Long- term loans and advances

e) Other Non-current Assets
Current assets
a) Inventories

1
1

b) Trade Receivables

0.85

1 Non- current assets

a) Fixed Assets

I
I
I

9.15

2.62

B ASSETS

I
I

1.30

49.30

d) Short term provisions

!
I
I

Liabilities

a) Short term borrowings

l,,

funds

Liabilities

l;
i

1008.37

a) Share Capital
b) Reserves & Surplus

c) Cash and Cash equivalents

d) Short- term loans and advances
e)

Other current assets

Sub-total - Current Assets
TOTAL - ASSETS
For Omkar Pharmachem

40.73

9.08

972.02

940.38

Limted

AnU,.gS~~
Managing Director
Place: AJunedabad

DIN: 02289261

Date: 30th May, 2016

A-727, Sarita Vihar, New delhi -110076

..

Rajesh J. Shah & Associates

,~

Chartered Accountants
"""

CA
To The Board of Directors,
Omkar Pharmachem Limited,
Ahmedabad
We have audited the quarterly financial results of Omkar Pharmachem Limited for the quarter
ended 31 st March, 2016 and the year to date results for the period 1st April, 2015 to 31 st March, .
2016, attached herewith, being submitted by the company pursuant to the requirement of
Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
~ 2015. These quarterly financial results as well as the year to date financial results have been
prepared on the basis of the interim financial statements, which are the responsibility of the
company's management. Our responsibility is to express an opinion on these financial results
based on our audit of such interim financial statements, which have been prepared in accordance
with the recognition and measurement principles laid down in Accounting Standard for Interim
Financial Reporting (AS 2f / Ind AS 34), prescribed, under SectionTB of the Companies Act,
2013 read with relevant ru es issued there under; or by the Institute of Chartered Accountants of
Indiai, as applicable and ot er accounting principles generally accepted in India.
I

We conducted our audit in accordance with the auditing standards generally accepted in India.
Those standards require that we plan and perform the audit to obtain reasonable assurance about
whether the financial results are free of material misstatement(s). An audit includes examining,
on a test basis, evidence supporting the amounts disclosed as financial results. An audit also .
includes assessing the accounting principles used and significant estimates made by
management. We believe that our audit provides a reasonable basis for our opinion.
In our opinion and to the best of our information and according to the explanations given to us
these quarterly financial results as well as the year to date results:
(i) are presented in accordance with the requirements of Regulation 33 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 in this regard; and
(ii) give a true and fair view of the net profit/loss and other financial information for the quarter
ended 31 st March, 2016 as well as the year to date results for the period from 1st April, 2015 to
31 st March, 2016.
For Rajesh J. Shah & Associates
Chartered Accountants
FRNI08407W

Partner
Mem. No. 040268
Place: Ahmedabad
Date : 30/0512016

B-110-111, Gopal Palace, Opp. Ocean Park, Nr. Nehrunagar BRTSStop, Nehrunagar-Satellite
Road,Satellite, Ahmedabad-380015
Tel.No. 079-26760537 / 26760637 / 26767637 M. No. (KBP) 94260 08343, (RJS)9824045695,
info@rajeshjshahca.com
/ rjshah_ca@yahoo.com
www.rajeshjshahca.com/rajeshjshahassociates.icai.org.in

OMKAR PHARMACHEM LIMITED

CIN L24231GJ199SPLC02S276

SOl, Mahakant Building,

Opp. V.S. Hospital,
Ashram road, Ellisbridge,
Ahmedabad-380 006.
Website www.omkarpharmachem.co.in
Email investors.opl@gmail.com

FORM A (for audit report with unmodified opinion)

1.
2.

Name of the corn an

Annual financial statements

3.

OMKAR PHARMACHEM LIMITED

31st March, 2016
UnModified

e Managing Director

(Anurag Sharma)

@CFO

(Gaurav Kathuria)

For Rajesh J. Shah & Associates

Chartered Accountants
FRNI08407W
!?l

Auditor of the company

Partner
Mem. No. 040268

Audit Committee Chairman

(Ms. Marnta Pachori)